![Shu Qing Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shu Qing Wu
Vorsitzender bei
CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.
Profil
Ms. Shu Qing Wu is a Chairman-Supervisory Board at Chengdu Kanghua Biological Products Co., Ltd. and a Senior Partner & Finance Business Unit President at Yingke Innovation Asset Management Co. Ltd. She is on the Board of Directors at Adlai Nortye USA, Inc., Hangzhou Adlai Nortye Biopharma Co. Ltd., Guangxi Ruiying Asset Management Co., Ltd., Phylion Battery Co., Ltd. and Yingke Innovation Asset Management Co. Ltd. Ms. Wu was previously employed as a Non-Executive Director by Adlai Nortye Ltd. and a Chairman-Supervisory Board by Nanjing Aolian AE & EA Co., Ltd. She received her undergraduate degree from Yang-En University.
Aktive Positionen von Shu Qing Wu
| Unternehmen | Position | Beginn |
|---|---|---|
| CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD. | Vorsitzender | 16.07.2018 |
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | 01.08.2020 |
Adlai Nortye USA, Inc. | Direktor/Vorstandsmitglied | 01.08.2020 |
Guangxi Ruiying Asset Management Co., Ltd.
 Guangxi Ruiying Asset Management Co., Ltd. Financial ConglomeratesFinance Provides investment services | Direktor/Vorstandsmitglied | - |
Yingke Innovation Asset Management Co. Ltd.
 Yingke Innovation Asset Management Co. Ltd. Investment ManagersFinance Yingke PE invests in companies located in China. The firm focuses on life sciences, dual carbon technology & hard core technology. It provides financing for buyout capital requirements. | Direktor/Vorstandsmitglied | - |
Phylion Battery Co., Ltd.
 Phylion Battery Co., Ltd. Electrical ProductsProducer Manufacturing Manufactures and sells lithium-ion cells | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Shu Qing Wu
| Unternehmen | Position | Ende |
|---|---|---|
| NANJING AOLIAN AE&EA CO.,LTD | Vorsitzender | - |
| ADLAI NORTYE LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Shu Qing Wu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Phylion Battery Co., Ltd.
Phylion Battery Co., Ltd. Electrical ProductsProducer Manufacturing Manufactures and sells lithium-ion cells | Producer Manufacturing |
Nanjing Aolian AE & EA Co., Ltd.
 Nanjing Aolian AE & EA Co., Ltd. Auto Parts: OEMProducer Manufacturing Manufactures automobile electronics and electrical accessory products | Producer Manufacturing |
Yang-En University
 Yang-En University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chengdu Kanghua Biological Products Co., Ltd.
 Chengdu Kanghua Biological Products Co., Ltd. BiotechnologyHealth Technology Engages in research, development, production and sale of vaccines & biological products | Health Technology |
Yingke Innovation Asset Management Co. Ltd.
Yingke Innovation Asset Management Co. Ltd. Investment ManagersFinance Yingke PE invests in companies located in China. The firm focuses on life sciences, dual carbon technology & hard core technology. It provides financing for buyout capital requirements. | Finance |
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Guangxi Ruiying Asset Management Co., Ltd.
Guangxi Ruiying Asset Management Co., Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Adlai Nortye Ltd.
 Adlai Nortye Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceuticals for cancer immunotherapy | Commercial Services |
Adlai Nortye USA, Inc. |
